What is it about?

Intermediate HCC is heterogeneous, it is necessary to find a suitable. strategy for subtype HCC.

Featured Image

Why is it important?

We identified subgroup B1 HCC to assess the efficacy of combination of TACE and RFA. The results showed that combination treatment of TACE and RFA gained longer overall survival and progression survival.

Perspectives

I hope this article can help clinicians get a new sight of intermediate HCC, and perform a better treatment strategy for specific patients.

Fu-rong Liu
Sun Yat-Sen University

Read the Original

This page is a summary of: Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma, Journal of Oncology, September 2019, Hindawi Publishing Corporation,
DOI: 10.1155/2019/6298502.
You can read the full text:

Read
Open access logo

Contributors

The following have contributed to this page